Literature DB >> 2852695

Clinical use of the somatostatin analog SMS 201-995 in endocrinology.

R Cozzi1, A Liuzzi, D Dallabonzana, G Oppizzi, P Orlandi, C De Palo, M M Petroncini, M Piolini, P G Chiodini.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 2852695     DOI： 10.1007/BF03350937

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  9 in total

1.  Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.

Authors:  L K Kvols; C G Moertel; M J O'Connell; A J Schutt; J Rubin; R G Hahn
Journal:  N Engl J Med       Date:  1986-09-11       Impact factor: 91.245

Review 2.  Somatostatin.

Authors:  S Reichlin
Journal:  N Engl J Med       Date:  1983-12-15       Impact factor: 91.245

3.  SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.

Authors:  W Bauer; U Briner; W Doepfner; R Haller; R Huguenin; P Marbach; T J Petcher
Journal:  Life Sci       Date:  1982-09-13       Impact factor: 5.037

4.  Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses.

Authors:  J C Reubi; P U Heitz; A M Landolt
Journal:  J Clin Endocrinol Metab       Date:  1987-07       Impact factor: 5.958

5.  Somatostatin receptors in human endocrine tumors.

Authors:  J C Reubi; R Maurer; K von Werder; J Torhorst; J G Klijn; S W Lamberts
Journal:  Cancer Res       Date:  1987-01-15       Impact factor: 12.701

6.  Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine.

Authors:  P G Chiodini; R Cozzi; D Dallabonzana; G Oppizzi; G Verde; M Petroncini; A Liuzzi; E del Pozo
Journal:  J Clin Endocrinol Metab       Date:  1987-03       Impact factor: 5.958

7.  Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue.

Authors:  R J Comi; N Gesundheit; L Murray; P Gorden; B D Weintraub
Journal:  N Engl J Med       Date:  1987-07-02       Impact factor: 91.245

Review 8.  A guide to the clinical use of the somatostatin analogue SMS 201-995 (Sandostatin).

Authors:  S W Lamberts
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1987

9.  Hyperthyroidism due to non-tumoural inappropriate TSH secretion. Effect of a long-acting somatostatin analogue (SMS 201-995).

Authors:  G Williams; M Kraenzlin; L Sandler; J Burrin; A Law; S Bloom; G F Joplin
Journal:  Acta Endocrinol (Copenh)       Date:  1986-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.